Ibon Gurruchaga-Sotes (Ibon Gurruchaga Sotés)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Radiation Therapy

Chronic Myeloid Leukemia

Clinical Practice

Top Venues

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Ibon Gurruchaga-Sotes, M Carmen Gómez-Mateo, María Eugenia Ortega Izquierdo, Javier Martínez Trufero
Beneficial Use of the Combination of Gemcitabine and Dacarbazine in Advanced Soft Tissue Sarcomas: Real-World Data. Cancers 16 (2) (2024)
Ibon Gurruchaga-Sotes, M Carmen Gómez-Mateo, María Eugenia Ortega Izquierdo, Javier Martínez Trufero
Beneficial Use of the Combination of Gemcitabine and Dacarbazine in Advanced Soft Tissue Sarcomas: Real-World Data. Cancers 16 (2) (2024)
Ibon Gurruchaga-Sotes, Ana Nuño Alves, Sandra Vicente Arregui, Carmen Santander Lobera
Response to Combination of Pembrolizumab and Axitinib in Hereditary Leyomiomatosis and Renal Cell Cancer (HLRCC). Current oncology (Toronto, Ont.) 28 (4) (2021)
Javier Martínez Trufero, Luis Miguel De Sande-González, Pablo Luna, Javier Martín-Broto, Rosa Álvarez Álvarez, Gloria Marquina, Roberto Diaz-Beveridge, Andrés Poveda, Juana María Cano, Josefina Cruz-Jurado, Antonio López Pousa, María Angeles Vaz Salgado, Claudia M Valverde-Morales, Isabel Sevilla, Jerónimo Martínez-García, Jordi Rubio Casadevall, Ana De Juan, Juan Antonio Carrasco, David S Moura, Ibon Gurruchaga-Sotes, Antonio Gutierrez
A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study. Cancers 13 (4) (2021)